Suppliers / Unimark Remedies

Unimark Remedies

India 538 employees Updated 9 July 2026

Unimark Remedies is an API manufacturer based in India. It holds 34 active US drug master files across a filed portfolio of 26 molecules. Its filings concentrate with EMA, FAMHP (BE) and INFARMED (PT). Its GMP standing is certified by CDSCO (India).

34
active US DMFs
0
valid CEPs
1
registered plants
13
filings across 5 regulators

Registered plants

Site FDA FEI
Valsad, India Not on file

What they file, and where

Molecule Regulators Docs
Nitrofurantoin US FDA 4
Cilastatin US FDA 2
Doripenem US FDA 2
Flecainide US FDA 2
Imipenem US FDA 2
Lisinopril SFDA (Saudi Arabia), US FDA 2
Meropenem US FDA 2
Moxifloxacin SFDA (Saudi Arabia), US FDA 2
Ramipril SFDA (Saudi Arabia), US FDA 2
Topiramate US FDA 2
Show all 26 molecules on file
Albendazole US FDA 1
Armodafinil US FDA 1
Benazepril US FDA 1
Buspirone US FDA 1
Cefixime US FDA 1
Cefuroxime US FDA 1
Dronedarone US FDA 1
Lamotrigine US FDA 1
Meloxicam US FDA 1
Monelukast SFDA (Saudi Arabia) 1
Montelukast US FDA 1
Paliperidone US FDA 1
Pimozide US FDA 1
Rizatriptan US FDA 1
Solifenacin Succinate US FDA 1
Tigecycline US FDA 1

Also appears on these molecule pages

Albendazole API Cefixime API Cefuroxime API Lamotrigine API Lisinopril API Meloxicam API Meropenem API Montelukast API Moxifloxacin API Nitrofurantoin API Ramipril API Topiramate API
Show 1 more molecule pages
Solifenacin API

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 4 None
FAMHP (BE) 3 None
INFARMED (PT) 3 None
Health Canada 2 None
MINSA (CR) 1 None
CDSCO (India) None 2

Comparing suppliers?

Choose your molecules and target markets. Unimark Remedies comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 1 active litigation matter is on record.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates